The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Breast Cancer

Revised text to state that the selective use of MRI for additional screening is being used with increased frequency despite the absence of randomized, controlled data. Added Solin et al. as reference 19 and Morrow as reference 20.

Stage I, II, IIIA, and Operable IIIC Breast Cancer

Added text on a study of SLN resection and axillary dissection in women with node-negative breast cancer (cited Krag et al. as reference 51).

Added text on a study of adjuvant treatment in premenopausal women with node-positive breast cancer (cited Schmid et al. as reference 130).

Added text on a study of HER2 status and the efficacy of adjuvant anthracyclines in early breast cancer (cited Gennari et al. as reference 162).

Added text on a study of taxane-based combinations as adjuvant chemotherapy for early breast cancer (cited De Laurentiis as reference 163 and level of evidence 1iiA).

Added text on a study of weekly paclitaxel in the adjuvant treatment of breast cancer (cited Sparano et al. as reference 164 and level of evidence 1iiA).

Added Rastogi et al. as reference 202.

Stage IIIB, Inoperable IIIC, IV, Recurrent, and Metastatic Breast Cancer

Added Seidman et al. as reference 58 and Gonzalez-Angulo et al. as reference 59.

Added Venturini et al. as reference 64.

Added capecitabine and ixabepilone as a combination regimen that has shown activity in metastatic breast cancer (cited Thomas et al. as reference 75).

Back to Top

< Previous Section  |  Next Section >